» Articles » PMID: 38421468

Ivermectin Exerts Anticonvulsant Effects Against Status Epilepticus Induced by Lithium-Pilocarpine in Rats Via GABA Receptor and Neuroinflammation Modulation: Possible Interaction of Opioidergic Pathways and K Channel with Nitrergic System

Overview
Journal Mol Neurobiol
Date 2024 Feb 29
PMID 38421468
Authors
Affiliations
Soon will be listed here.
Abstract

Status epilepticus (SE) is a critical medical emergency marked by persistent or rapidly repeating seizures, posing a threat to life. Using the lithium-pilocarpine-induced SE model, we decide to evaluate the anti-seizure effects of ivermectin as a positive allosteric modulator of GABA receptor and the underlying mechanisms involved. Lithium chloride was injected intraperitoneally at a dose of 127 mg/kg, followed by the administration of pilocarpine at a dose of 60 mg/kg after a 20-h interval in order to induce SE. Subsequently, the rats received varying amounts of ivermectin (0.3, 1, 3, 5, and 10 mg/kg, i.p.) 30 min before the onset of SE. To study the underlying molecular mechanisms, we had pharmacological interventions of diazepam (1 mg/kg), glibenclamide and nicorandil as ATP-sensitive potassium channel blocker and opener (both 1 mg/kg, i.p.), naltrexone and morphine, as opioid receptor antagonist and agonist (1 mg/kg and 0.5 mg/kg, i.p., respectively). In addition, three nitric oxide inhibitors, namely, L-NAME (10 mg/kg, i.p.), 7-NI (30 mg/kg, i.p.), and aminoguanidine (100 mg/kg, i.p.), were administered to the rats in the experiment. Finally, we use ELISA and western blotting, respectively, to examine the amounts of pro-inflammatory cytokines (TNF-α and IL-1β), nitrite, and GABA receptors in the rat hippocampal tissue. The study found that ivermectin, at doses of 3, 5, and 10 mg/kg, exerts anti-seizure effects and decrease Racine's scale SE score. Interestingly glibenclamide and naltrexone reduced the anti-seizure effects of ivermectin, and from other hand diazepam, nicorandil, morphine, L-NAME, 7-NI, and aminoguanidine, enhance the effects when co-administrated with subeffective dose of ivermectin. Additionally, the study found that ivermectin decreased the elevated levels of TNF-α and IL-1β following SE, while increased the reduced expression of GABA receptors. Overall, these findings suggest that ivermectin has anti-seizure effects in a SE seizure which may be mediated by the modulation of GABAergic, opioidergic, and nitrergic pathways and K channels.

Citing Articles

Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways.

Balabandian M, Manavi M, Lesani A, Mohammad Jafari R, Shafaroodi H, Heidari N Pharmacol Res Perspect. 2025; 13(2):e70079.

PMID: 39996441 PMC: 11851161. DOI: 10.1002/prp2.70079.


Acute anticonvulsant effects of dapsone on PTZ- and MES-induced seizures in mice: NLRP3 inflammasome inhibition and Nrf2/HO-1 pathway preservation.

Lesani A, Mashaknejadian Behbahani F, Manavi M, Mohammad Jafari R, Shafaroodi H, Khosravi S Pharmacol Rep. 2025; .

PMID: 39869286 DOI: 10.1007/s43440-025-00698-6.


Anticonvulsant effects of pentoxifylline on seizures induced by pentylenetetrazole and maximal electroshock in male mice: The role of the nitrergic pathway.

Keshavarzi M, Ghasemi M, Manavi M, Dehpour A, Shafaroodi H IBRO Neurosci Rep. 2024; 17:485-492.

PMID: 39717871 PMC: 11664280. DOI: 10.1016/j.ibneur.2024.11.013.


Ivermectin as a promising therapeutic option for onchocerciasis-associated epilepsy.

Manavi M, Mohammad Jafari R, Shafaroodi H, Sharifzadeh M, Dehpour A Epilepsia Open. 2024; 10(1):361-367.

PMID: 39585722 PMC: 11803276. DOI: 10.1002/epi4.13107.


Spermidine Exerts Protective Effects in Random-Pattern Skin Flap Survival in Rats: Possible Involvement of Inflammatory Cytokines, Nitric Oxide, and VEGF.

Jouyban K, Mohammad Jafari R, Charkhpour M, Rezaei H, Seyfinejad B, Manavi M Aesthetic Plast Surg. 2024; 48(17):3500-3509.

PMID: 38755497 DOI: 10.1007/s00266-024-04119-6.

References
1.
Treiman D, Meyers P, Walton N, Collins J, Colling C, Rowan A . A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998; 339(12):792-8. DOI: 10.1056/NEJM199809173391202. View

2.
Trinka E, Cock H, Hesdorffer D, Rossetti A, Scheffer I, Shinnar S . A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015; 56(10):1515-23. DOI: 10.1111/epi.13121. View

3.
Cerne R, Lippa A, Poe M, Smith J, Jin X, Ping X . GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA receptors. Pharmacol Ther. 2021; 234:108035. PMC: 9787737. DOI: 10.1016/j.pharmthera.2021.108035. View

4.
Chuang Y, Chen S, Lin T, Liou C, Chang W, Chan S . Upregulation of nitric oxide synthase II contributes to apoptotic cell death in the hippocampal CA3 subfield via a cytochrome c/caspase-3 signaling cascade following induction of experimental temporal lobe status epilepticus in the rat. Neuropharmacology. 2007; 52(5):1263-73. DOI: 10.1016/j.neuropharm.2007.01.010. View

5.
Manavi M . Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy and associated comorbidities. Neuropeptides. 2022; 94:102250. DOI: 10.1016/j.npep.2022.102250. View